728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads

The Welch Foundation Announces 2018 Norman Hackerman Award Recipient

THIS POST WAS ORIGINALLY PUBLISHED ON THIS SITE Click Here To Read Entire Article

HOUSTON, Feb. 1, 2018 /PRNewswire/ — The Welch Foundation today announced that Dr. Jeffrey D. Rimer is the recipient of the 2018 Norman Hackerman Award in Chemical Research. Having already made significant scientific contributions in the areas of energy and drug development, Dr. Rimer is being recognized as a ‘rising star’ in his field.

2018 Norman Hackerman Award in Chemical Research recipient Dr. Jeffrey D. Rimer

“As the foundation is based in Houston, this is a special opportunity to recognize a researcher who lives and works in our hometown,” said Carin Barth, Director and Chair, The Welch Foundation. “Dr. Rimer’s vast achievements are further proof that some of the brightest minds in chemistry are in Texas.”

Currently an Associate Professor in the Department of Chemical and Biomolecular Engineering at the University of Houston, Dr. Rimer is known for his ability to apply multiple scientific disciplines to his research, producing breakthroughs that have immediate applications in materials science.

“The Welch Foundation has made a significant impact on my research program,” said Dr. Rimer. “The Foundation’s funding is unique in that it is not tied to specific applications or agendas, but instead supports fundamental research on the merits of the problems being addressed. This provides tremendous latitude for researchers to be creative and pursue scientifically-driven studies. Support from the foundation also opens avenues for high-impact discoveries and the establishment of new research directions. Indeed, funding from The Welch Foundation has allowed my group to develop completely new areas of research that would have been impossible to accomplish without their support.”

Dr. Rimer’s lab has made two significant research discoveries in the past decade, the first being that of a molecule that inhibits calcium oxalate crystallization, the principal component of kidney stones. This promising therapeutic is a major advancement in drug development and has the potential to replace drugs currently used to treat this widespread disease. The second notable discovery is the development of techniques to elucidate complex pathways of non-classical crystallization, inspiring new methods to optimize the synthesis of zeolites, which are important as catalysts in petrochemical industries.

“Dr. Rimer is widely recognized as an outstanding teacher and mentor, as evidenced by the deep scholarship and innovation produced in his lab,” said Peter B. Dervan, Chair, The Welch Foundation Scientific Advisory Board. “He has

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *